ログアウトされました

脳神経外科

水頭症と脳圧管理

重力可変式バルブは治療効果を高めます

医療従事者の確認

この先は、医療従事者の方を対象とした情報を提供しております。 大変申し訳ございませんが、医療従事者の方以外はご遠慮ください。


あなたは医療従事者ですか?


確認 はい、わたしは医療従事者です. キャンセル いいえ、わたしは医療従事者ではありません.

MIETHKE proGAV® 2.0

MIETHKE gravitational valves provide a reliable solution in prevention of overdrainage complications [1, 2] associated with the management of hydrocephalus.proGAV® 2.0 represents the latest development by refining our existing proGAV® technology to better meet the needs of our customers and their patients.proGAV® 2.0 offers the reliability of our existing technology with a new tactile “Feedback” mechanism and “Soft-Touch” instrumentation. The adjustable unit is equipped with a special valve surface: By using slight pressure with your finger, the “Active-Lock” mechanism of the valve is released and a tactile feedback is received.The combination of the refined proGAV® technology and “Soft-Touch” instrumentation provides comfort for patients and security against inadvertent readjustment caused by magnetic fields up to 3 Tesla [3].With the new proGAV® 2.0 Compass the opening pressure of the adjustable unit can be identified quickly, without having to expose the patient to X-ray.Indication:Treatment of Hydrocephalus

MIETHKE proSA®

The MIETHKE proSA® Shunt System represents the first generation of adjustable gravitational valves that allow postoperative adaptation to the individual needs of the patient for the upright body position. [1,2]It offers effective protection against overdrainage through an individually and continuously adjustable large opening pressure range of 0-40 cmH2O [3,4]The patented verification and adjustment instruments enable a simple, quick and uncomplicated adjustment of the pressure level without having to perform X-rays that are stressful for the patient. [3,4,5,6]Indication:Treatment of Hydrocephalus

MIETHKE miniNAV®

The MIETHKE miniNAV® was developed as a compact differential pressure valve which, due to its small design, is particularly suitable for the treatment of pediatric hydrocephalus, especially in premature and newborn infants.[1] Another area of application is hydrocephalus in bedridden patients.The valve is made of titanium, a material that allows excellent precision, stability and biocompatibility.Indication:Treatment of Hydrocephalus

MINOP®

MINOP® is an intraventricular neuroendosopic system designed primarily for the treatment of intraventricular indications such as occlusive hydrocephalus and the removal of tumors and cysts.BenefitsModular, sophisticated designTrocar with rounded tip for less traumatic insertion into the brainLarge depth scale for safer positioning and better control inside the ventriclesOptimized optical components leading to an enlarged image area, higher image quality, brightness and contrastAngled design for enhanced instrument maneuverabilityFeatures:Trocar withAttachment for connection of peripheral devicesAdditional single obturator for the working channel for insertion under visual control, with the 0° endoscopeFull HD compatible endoscopes with different directions of view (0° and 30°)Special micro instrumentsDetachable tube shaft instruments with tactile feedback and rotatable instrument tip for improved control and enhanced handling and precisionFlexible instruments for bi-instrumental working (with both hands)Monopolar and bipolar electrodesSingle-use suction cannulasAdditional information:Single-use introducer for preserving the brain in case of repeated insertion and withdrawal of the endoscopic system during an operationAdapter for fixation to Aesculap® holding devicesDedicated baskets for sterilization and storage

[1] Tschan CA, Antes S, Huthmann A, et al. Overcoming CSF overdrainage with the adjustable gravitational valve proSA. Acta Neurochir (Wien). 2014;156(4):767-76; discussion 776.

[2] Suchorska B, Kunz M, Schniepp R, et al. Optimized surgical treatment for normal pressure hydrocephalus: comparison between gravitational and differential pressure valves. Acta Neurochir (Wien). 2015;157(4):703-9.

[3] Lemcke J, Meier U, Muller C, et al. Safety and efficacy of gravitational shunt valves in patients with idiopathic normal pressure hydrocephalus: a pragmatic, randomised, open label, multicentre trial (SVASONA). J Neurol Neurosurg Psychiatry. 2013;84(8):850-7

[4] Sprung C, Schlosser HG, Lemcke J, et al. The adjustable proGAV shunt: a prospective safety and reliability multicenter study. Neurosurgery. 2010;66(3):465-74.

[5] Chari A, Czosnyka M, Richards HK, Pickard JD, Czosnyka ZH. Hydrocephalus shunt technology: 20 years of experience from the Cambridge Shunt Evaluation Laboratory. J Neurosurg. 2014;120(3):697-707.

[6] Antes S, Stadie A, Muller S, et al. Intracranial Pressure-Guided Shunt Valve Adjustments with the Miethke Sensor Reservoir. World Neurosurg. 2018;109:e642-e50.

[7] Freimann FB, Schulz M, Haberl H, et al. Feasibility of telemetric ICP-guided valve adjustments for complex shunt therapy. Childs Nerv Syst. 2014;30(4):689-97.

[8] Thompson S, Thorne L, Toma A, et al. Telemetric monitoring of ICP within a shunt system. A single centre experience including the first in vivo comparison versus conventional intraparenchymal monitoring. Fluids and Barriers of the CNS. 2017;14(Suppl 1):A63.